Chugai Pharmaceutical Co's quarterly market cap
increased
from Sep. 2023 ($50,612 Mil) to Dec. 2023 ($62,028 Mil) and
increased
from Dec. 2023 ($62,028 Mil) to Mar. 2024 ($62,952 Mil).
Chugai Pharmaceutical Co's annual market cap
declined
from Dec. 2021 ($53,802 Mil) to Dec. 2022 ($41,667 Mil) but then
increased
from Dec. 2022 ($41,667 Mil) to Dec. 2023 ($62,028 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Chugai Pharmaceutical Co's Enterprise Value for Today is $45,709 Mil.
Chugai Pharmaceutical Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Chugai Pharmaceutical Co's Market Cap
For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chugai Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Chugai Pharmaceutical Co's Market Cap falls into.
Chugai Pharmaceutical Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Chugai Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chugai Pharmaceutical Co (OTCPK:CHGCY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Chugai Pharmaceutical Co Market Cap Related Terms
Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Business Description
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding Ltd, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and COVID-19.
Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHGCY has been successfully added to your 